Publicação

Anti-SARS-COV-2 humoral immunity in ULSNE healthcare professionals

Ver documento

Detalhes bibliográficos
Resumo:The detection of specific antibodies can provide information on the immunity achieved against SARS-CoV-2 infection. The new coronavirus-2 S protein is the main target used in COVID-19 vaccine development. Infection and vaccination in COVID-19 induce an antibody response against the Spike (S) glycoprotein. The administration of the vaccine appears to be an effective prophylactic strategy and there is scientific data showing that vaccination is responsible for reducing the number of infections, severe symptoms and COVID-19 associated deaths.
Autores principais:Pereira, Tifany
Outros Autores:Caldeira, Maria João; Rodrigues, Ângela; Gonçalves, Viviane; Montanha, Maria José; Rodrigues, Carina
Assunto:SARS-CoV-2 COVID-19 Humoral Immunity Health Professionals
Ano:2022
País:Portugal
Tipo de documento:póster em conferência
Tipo de acesso:acesso aberto
Instituição associada:Instituto Politécnico de Bragança
Idioma:inglês
Origem:Biblioteca Digital do IPB
Descrição
Resumo:The detection of specific antibodies can provide information on the immunity achieved against SARS-CoV-2 infection. The new coronavirus-2 S protein is the main target used in COVID-19 vaccine development. Infection and vaccination in COVID-19 induce an antibody response against the Spike (S) glycoprotein. The administration of the vaccine appears to be an effective prophylactic strategy and there is scientific data showing that vaccination is responsible for reducing the number of infections, severe symptoms and COVID-19 associated deaths.